Medical News

RSS

Novel topically-applied molecular microbicide protects women against HIV infection

Using a technique that silences genes promoting infection, researchers have developed a novel, topically-applied molecular microbicide capable of preventing HIV transmission.

17 May 2011

Innovative collaboration between physics and cell biology demonstrates pathway

An unusual collaboration between cell and developmental biologists and physicists at UNC-Chapel Hill is providing insights into the relationship between the physical properties of cells and the signals that influence cell behavior.

17 May 2011

Obese patients undergoing colon surgery more likely to develop costly surgical-site infections

Obese patients undergoing colon surgery are 60 percent more likely to develop dangerous and costly surgical-site infections than their normal-weight counterparts, new Johns Hopkins research suggests.

17 May 2011

Gingrich calls GOP Medicare voucher plan radical

Now that he is officially in the running to be the Republican nominee for president, Newt Gingrich made his opinions very clear while appearing on Sunday morning talk shows.

17 May 2011

MHAUS sponsors one-day conference on Malignant Hyperthermia

Medical professionals, patients and families can learn the basics on how recognize, diagnose, and treat Malignant Hyperthermia at a one-day Malignant Hyperthermia conference happening from 10 am to 4 pm June 25 at Lake Receptions located in Mt. Dora, Florida.

17 May 2011

Sanofi hopes to launch dengue vaccine in 2014

France's Sanofi-Pasteur, the world's largest vaccine maker, said Friday it hopes to introduce a dengue vaccine in 2014 to some high-risk nations, AlertNet reports. The vaccine is in the last stage of clinical testing in Australia, and the company said it hopes to produce 100 million doses of the vaccine annually, according to the news agency.

17 May 2011

MEDRAD's Cotavance catheter with Paccocath technology receives European CE Mark approval

MEDRAD, INC., a business of Bayer HealthCare, today announced it has received CE Mark for its Cotavance Paclitaxel Coated Balloon Angioplasty Catheter with Paccocath technology.

17 May 2011

High IGF-I hormone levels linked with better long-term recovery after stroke

Insulin-like growth factor I, IGF-I, is a hormone that is found in the blood and contributes to, among other things, growth and bone mass. The levels of this hormone are higher in people who exercise regularly and those with good health. Scientists at the Sahlgrenska Academy have shown for the first time that high levels of this hormone are associated with better long-term recovery after a stroke.

17 May 2011

Thermo Fisher Scientific announces completion of Dionex tender offer

Thermo Fisher Scientific, the world leader in serving science, today announced that it has successfully completed its tender offer for Dionex Corporation.

From Thermo Fisher Scientific Inc. 17 May 2011

WHO releases annual World Health Statistics report

The WHO on Friday released its annual World Health Statistics report, which includes data on more than 100 indicators - such as life expectancy, mother and child mortality, disease prevalence and health expenditures - from the agency's 193 member states, the Associated Press reports (5/14).

17 May 2011

CytRx sells global rights of molecular chaperone assets to Orphazyme

CytRx Corporation, a biopharmaceutical company specializing in oncology, today announced that it has sold the worldwide rights to its molecular chaperone assets to privately-held, Copenhagen, Denmark-based Orphazyme ApS.

17 May 2011

Eli Lilly responds to Amylin's exenatide lawsuit

Eli Lilly and Company has provided additional perspective in response to Amylin Pharmaceuticals, Inc.'s lawsuit filed in the United States District Court for the Southern District of California.

17 May 2011

Anti-inflammatory drug celecoxib reacts with protein and induces liver cancer cells to commit suicide

The anti-inflammatory drug celecoxib, known by the brand name Celebrex, triggers liver cancer cell death by reacting with a protein in a way that makes those cells commit suicide, according to a new study.

17 May 2011

Epichem signs exclusive distributor agreement with AR Brown

Australian supplier of API analytical standards Epichem, announced today it has signed an exclusive distributor agreement with a leading Japanese Life Sciences supplier company, AR Brown, for sales to Japan, Taiwan, China and South Korea.

17 May 2011

Pediatric researchers find potential tools for controlling cytokine storm

By analyzing complex interactions of the immune system in an animal study, pediatric researchers have found potential tools for controlling a life-threatening condition called a cytokine storm that may strike children who have juvenile arthritis and other autoimmune diseases.

17 May 2011

HealthPartners prescribes walking or exercise for patients with depression

Giving pedometers to patients screened for depression, HealthPartners Medical Group (HPMG) is prescribing walking or exercise in addition to medication and/or therapy as an effective tool in helping patients with depression.

17 May 2011

ESC calls for single co-ordinated European system to oversee evaluation, approval of medical devices

The European Society of Cardiology (ESC) is calling for a single, co-ordinated European system to oversee the evaluation and approval of medical devices. The call is being made in a paper published online in the European Heart Journal reporting on a conference held by the ESC in January 2011 looking to increase the input of medical experts in developing medical device policy.

17 May 2011

COPD Foundation to host biannual conference in the U.S. for the first time

Originally hosted in Europe on even calendar years, the COPD Conference series for researchers and healthcare professionals is coming to the U.S. for the first time. The COPD Foundation is hosting the COPD7USA Conference, named after the seventh COPD Conference held last summer in the U.K. COPD7USA will be held on December 3rd and 4th at the Crystal City Gateway Marriott, 1700 Jefferson Davis Highway, Crystal City, VA 22202.

17 May 2011

Benitec raises AU$8 million for gene silencing therapeutics

Benitec Ltd (ASX:BLT), a world leader in RNA-based gene silencing for human therapeutics, today announced its fully underwritten AU$8 million renounceable rights issue, incorporating an entitlement offer and a shortfall offer, had successfully closed oversubscribed.

17 May 2011

Super-resolution microscopy technique reveals how and why cell's defenses fail against plague

Researchers at Sandia National Laboratories have developed a super-resolution microscopy technique that is answering long-held questions about exactly how and why a cell's defenses fail against some invaders, such as plague, while successfully fending off others like E.coli.

17 May 2011